About Santo
At Polpharma, we are at the forefront of revolutionizing the pharmaceutical landscape through a relentless focus on innovation and technological advancement. As the largest Polish manufacturer of pharmaceuticals and a leader in the Central and Eastern European market, our mission is to provide patients with access to high-quality, affordable medicines. Our journey, which began in 1935, has evolved into a dynamic, international pharmaceutical group that leverages cutting-edge solutions across all facets of our operations. We are deeply invested in research and development, with three state-of-the-art R&D centers in Poland. Since 2000, we have invested over PLN 2.3 billion in the development of new products, a testament to our commitment to innovation. Our R&D efforts have resulted in a robust pipeline and numerous patent applications, solidifying our position as a key innovator in the industry. We are not just producing generic drugs; we are actively developing complex formulations and value-added medicines in critical therapeutic areas such as cardiology, gastroenterology, neurology, and ophthalmology.
Our innovation extends beyond product development into our manufacturing processes and digital infrastructure. We operate five modern manufacturing plants in Poland, where we have invested over PLN 2.5 billion since 2000 to ensure the highest standards of quality and efficiency. These facilities are equipped to produce a wide array of pharmaceutical forms, from solid dosage forms to sterile injectables. Embracing the digital transformation, we have implemented advanced systems like Oracle Agile PLM to streamline our processes, reducing cycle times and accelerating time-to-market for our products. This digital-first approach enhances our operational excellence and ensures a reliable supply of our 400 million medicine packages produced annually to over 35 markets worldwide. Through strategic partnerships and a forward-thinking approach, Polpharma is dedicated to shaping the future of healthcare, helping people live a healthy life in a healthy world by making modern, effective therapies more accessible to all.
FAQs
- When was Santo founded?
- Santo was founded in 1935.
- Who is the CEO of Santo?
- Markus Sieger is the CEO.
- What industries or markets does Santo operate in?
- Santo operates in the following markets: Pharmaceutical Manufacturing, Generic Drugs, Biotechnology, Healthcare, Cardiology Therapeutics, Neurology Therapeutics, Gastroenterology Therapeutics, Ophthalmology Therapeutics, research and development, and Pharmaceutical.
- How many employees does Santo have?
- Santo has 5000+ employees.
- Where does Santo have employees?
- Santo has employees in Poland.
- Is Santo hiring?
- Yes, Santo has 5 open remote jobs.
- Does Santo support remote work or working from home?
- Yes, Santo is a remote-friendly company.
- What employee benefits does Santo offer?
- Santo provides 10 benefits to their employees.
- Does Santo offer a four-day work week?
- No, Santo does not offer a four-day work week.
- What is Santo's tech stack?
- Santo has 7 technologies in their tech stack.
- What is Santo's website?
- Santo's website is polpharma.com.
